Mark A. Hurwitz

784 total citations
5 papers, 471 citations indexed

About

Mark A. Hurwitz is a scholar working on Management of Technology and Innovation, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark A. Hurwitz has authored 5 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Management of Technology and Innovation, 3 papers in Economics and Econometrics and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark A. Hurwitz's work include Intellectual Property and Patents (3 papers), Pharmaceutical Economics and Policy (3 papers) and Prostate Cancer Treatment and Research (2 papers). Mark A. Hurwitz is often cited by papers focused on Intellectual Property and Patents (3 papers), Pharmaceutical Economics and Policy (3 papers) and Prostate Cancer Treatment and Research (2 papers). Mark A. Hurwitz collaborates with scholars based in United States. Mark A. Hurwitz's co-authors include Richard E. Caves, Peter Temin, Michael D. Whinston, Ariel Pakes, Philip W. Kantoff, Jerome P. Richie, William Oh, Anthony V. D’Amico, A.V. D’Amico and D. Schultz and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The Journal of Law and Economics and Columbia Law Review.

In The Last Decade

Mark A. Hurwitz

4 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Hurwitz United States 4 409 186 165 78 54 5 471
C. Scott Hemphill United States 12 370 0.9× 42 0.2× 243 1.5× 37 0.5× 52 1.0× 34 472
Mattias Ganslandt Sweden 10 293 0.7× 31 0.2× 91 0.6× 33 0.4× 55 1.0× 19 345
Michael A. Carrier Netherlands 9 152 0.4× 30 0.2× 60 0.4× 26 0.3× 34 0.6× 66 254
Matthew Grennan United States 8 268 0.7× 39 0.2× 10 0.1× 149 1.9× 142 2.6× 15 388
Georges Siotis Spain 11 276 0.7× 12 0.1× 28 0.2× 8 0.1× 239 4.4× 28 401
Richard T. Thakor United States 11 196 0.5× 11 0.1× 35 0.2× 22 0.3× 62 1.1× 43 372
Xavier Martínez-Giralt Spain 7 286 0.7× 3 0.0× 130 0.8× 76 1.0× 132 2.4× 21 339
Mustafa Erdem Sakinç France 5 80 0.2× 8 0.0× 11 0.1× 11 0.1× 62 1.1× 9 201
Regina G. Okafor Nigeria 8 83 0.2× 2 0.0× 12 0.1× 67 0.9× 154 2.9× 16 303

Countries citing papers authored by Mark A. Hurwitz

Since Specialization
Citations

This map shows the geographic impact of Mark A. Hurwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Hurwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Hurwitz more than expected).

Fields of papers citing papers by Mark A. Hurwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Hurwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Hurwitz. The network helps show where Mark A. Hurwitz may publish in the future.

Co-authorship network of co-authors of Mark A. Hurwitz

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Hurwitz. A scholar is included among the top collaborators of Mark A. Hurwitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Hurwitz. Mark A. Hurwitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Oh, William, Mark A. Hurwitz, Anthony V. D’Amico, Jerome P. Richie, & Philip W. Kantoff. (2003). Neoplasms of the Prostate. 8 indexed citations
2.
D’Amico, A.V., D. Schultz, Mark A. Hurwitz, et al.. (2000). Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for patients with clinically localized prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 48(3). 171–171. 1 indexed citations
3.
Caves, Richard E., Michael D. Whinston, Mark A. Hurwitz, Ariel Pakes, & Peter Temin. (1991). Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry. 1991. 1–1. 281 indexed citations
4.
Hurwitz, Mark A.. (1991). Bundling Patented Drugs and Medical Services: An Antitrust Analysis. Columbia Law Review. 91(5). 1188–1188. 4 indexed citations
5.
Hurwitz, Mark A. & Richard E. Caves. (1988). Persuasion or Information? Promotion and the Shares of Brand Name and Generic Pharmaceuticals. The Journal of Law and Economics. 31(2). 299–320. 177 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026